Dividend Advisor Hotline – Friday, January 4, 2019

PFIZER INC., $43.00, New York symbol PFE, is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis).

Starting with the March 2019 payment, Pfizer will increase its quarterly dividend by 5.9%,… Read More

Q: Hi, Pat. Could I have your opinion on the ALPS Sector Dividend Dogs ETF? If one were considering a “Dogs of the Dow” approach, would this be an alternative? Thanks.

A: The ALPS Sector Dividend Dogs ETF, $43.27, symbol SDOG on New York (Units outstanding: 49.3 million; Market cap: $2.1 billion; www.alpssectordividenddogs.com), is an ETF that applies the “Dogs of the Dow” theory on a sector-by-sector basis using the stocks in the S&P 500. The… Read More

We make an exception for Pfizer

We generally recommend investors avoid pharmaceutical companies due to the huge costs and risks of developing new drugs.
However, Pfizer is an exception. We feel its large size makes it less dependent on the success or failure of any single drug. In addition, the stock has… Read More

These ETFs aim for value stocks

Here are two ETFs that emphasize value investing in their stock selection. Academic studies suggest that, on average, value stocks can produce better results than growth investing. Still, it’s important to look closely to see if they’re truly undervalued. They may, after all, only be… Read More